Aterian (NASDAQ:ATER) Posts Earnings Results, Beats Expectations By $0.30 EPS

Aterian (NASDAQ:ATER) issued its quarterly earnings data on Friday. The company reported ($0.39) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.69) by $0.30, Zacks reports. Aterian had a negative return on equity of 68.00% and a negative net margin of 27.52%.

Aterian Stock Performance

Shares of ATER stock traded down $0.06 during trading on Friday, hitting $1.09. The company had a trading volume of 487,062 shares, compared to its average volume of 3,047,473. The firm has a market capitalization of $11.80 million, a P/E ratio of -0.45 and a beta of 0.66. The stock’s 50-day moving average price is $0.74 and its 200 day moving average price is $0.74. Aterian has a one year low of $0.52 and a one year high of $2.10.

Institutional Investors Weigh In On Aterian

Several institutional investors have recently made changes to their positions in the stock. Goldman Sachs Group Inc. boosted its stake in shares of Aterian by 73.0% in the first quarter. Goldman Sachs Group Inc. now owns 21,392 shares of the company’s stock valued at $45,000 after buying an additional 9,026 shares during the period. Citadel Advisors LLC boosted its stake in shares of Aterian by 222.0% in the third quarter. Citadel Advisors LLC now owns 33,165 shares of the company’s stock valued at $35,000 after buying an additional 22,865 shares during the period. Susquehanna International Group LLP boosted its stake in shares of Aterian by 310.2% in the third quarter. Susquehanna International Group LLP now owns 40,512 shares of the company’s stock valued at $43,000 after buying an additional 30,637 shares during the period. Finally, XTX Topco Ltd bought a new stake in shares of Aterian in the second quarter valued at approximately $55,000. 7.02% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Aterian in a report on Monday, April 20th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company presently has a consensus rating of “Sell”.

About Aterian

Aterian Inc is a technology-driven consumer products company that leverages artificial intelligence and machine learning to develop, source and market branded household, health and personal care products. Through its proprietary data analytics platform, Aterian identifies emerging trends, forecasts demand and optimizes product selection, pricing and distribution. The company maintains a vertically integrated supply chain, overseeing manufacturing partnerships and logistics to support rapid product development and market entry.

Aterian’s portfolio spans a range of categories including home and kitchen, health and wellness, baby care, beauty tools and electronics accessories.